Generali Brasil Seguros S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8851
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Generali Brasil Seguros S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Generali Brasil Seguros S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Generali Brasil Seguros S.A. (Generali Brasil), a subsidiary of Assicurazioni Generali SpA, is an insurance company. The company offers a range of life and non-life insurance products catering to the requirements of individual and corporate clients in Brazil. Its portfolio of products include auto insurance, residential insurance, education programs, individual and group life insurance, personal accident insurance, family protection plans, condominium insurance, engineering insurance, transport insurance, equipment insurance and general liability insurance. The company also provides claims related services to its customers. It offer markets and distributes these products and services through a network of branches, service points, and subsidiaries in major cities of Brazil. Generali Brasil is headquartered in Rio de Janeiro, Brazil.

The company reported net premiums written of BRL535.4 million for the fiscal year ended December 2017 (FY2017), a decline of 21.4% over that in FY2016. Its premium earned was BRL465 million in FY2017, a decline of 3.3% over that in FY2016.

Scope

- Detailed information on Generali Brasil Seguros S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Generali Brasil Seguros S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Generali Brasil Seguros S.A. including a breakdown and examination of key business segments
- Intelligence on Generali Brasil Seguros S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Generali Brasil Seguros S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Generali Brasil Seguros S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Generali Brasil Seguros S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Generali Brasil Seguros S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Generali Brasil Seguros S.A.: Company Overview 6
Generali Brasil Seguros S.A.: Overview and Key Facts 6
Generali Brasil Seguros S.A.: Overview 6
Generali Brasil Seguros S.A.: Key Facts 6
Generali Brasil Seguros S.A.: Key Employees 7
Generali Brasil Seguros S.A.: Key Employee Biographies 8
Generali Brasil Seguros S.A.: Major Products and Services 9
Generali Brasil Seguros S.A.: Company History 10
Generali Brasil Seguros S.A.: Management Statement 11
Generali Brasil Seguros S.A.: Locations and Subsidiaries 12
Generali Brasil Seguros S.A.: Key Competitors 14
Generali Brasil Seguros S.A.: Company Analysis 15
Generali Brasil Seguros S.A.: Business Description 15
Generali Brasil Seguros S.A.: SWOT Analysis 16
Generali Brasil Seguros S.A.: SWOT Overview 16
Generali Brasil Seguros S.A.: Strengths 16
Generali Brasil Seguros S.A.: Weaknesses 17
Generali Brasil Seguros S.A.: Opportunities 17
Generali Brasil Seguros S.A.: Threats 17
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Generali Brasil Seguros S.A.: Key Facts
Table 2: Generali Brasil Seguros S.A.: Key Employees
Table 3: Generali Brasil Seguros S.A.: Company History
Table 4: Generali Brasil Seguros S.A.: Locations and Subsidiaries
Table 5: Generali Brasil Seguros S.A.: Key Competitors



★海外企業調査レポート[Generali Brasil Seguros S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • DiaCarta Inc:企業の製品パイプライン分析2018
    Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection ki …
  • Wright Medical Group NV (WMGI)-医療機器分野:企業M&A・提携分析
    Summary Wright Medical Group NV (Wright) is an international orthopedic medical device company with focus on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and hand; foot a …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務情報
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • InDex Pharmaceuticals Holding AB (INDEX):企業の財務・戦略的SWOT分析
    Summary InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical company that offers treatments for immunological diseases. The company’s lead compound cobitolimod, currently in the phase 2 stage, is intended for the treatment of moderate to severe treatment active refractory ulc …
  • Rangeland Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Rangeland Energy LLC (Rangeland Energy) is a midstream energy company. The company services include transloading, storing frac sand, moving inbound and outbound crude oil and associated natural gas products. It also provides Rangeland integrated oil systems, which is a multipart crude and sa …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Leidos Holdings Inc:企業の戦略・SWOT・財務情報
    Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tetra Tech Inc:企業の戦略・SWOT・財務分析
    Tetra Tech Inc - Strategy, SWOT and Corporate Finance Report Summary Tetra Tech Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Chubu Electric Power Co Inc:発電所・企業SWOT分析
    Chubu Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務分析
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Aoyama Trading Co., Ltd.
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • WB Electronics SA :企業の戦略・SWOT・財務情報
    WB Electronics SA - Strategy, SWOT and Corporate Finance Report Summary WB Electronics SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Omega Diagnostics Group Plc (ODX):企業の財務・戦略的SWOT分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests …
  • Kolon Life Science Inc (102940):製薬・医療:M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • Newfoundland and Labrador Hydro:企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Tonix Pharmaceuticals Holding Corp (TNXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Escalon Medical Corp (ESMC)-医療機器分野:企業M&A・提携分析
    Summary Escalon Medical Corp (Escalon) is a medical device company with focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachymeters, co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆